17th June 2009
European Society of Cardiology
Summary,

Source: National Guidelines Clearinghouse

DISEASE/CONDITION(S)
Cardiovascular disease including:

• Acute myocardial infarction (AMI)
• Non-ST-segment elevation acute coronary syndromes
• Chronic, stable ischaemic heart disease
• Heart failure
• Arrhythmias
• Hypertension
• Dilated cardiomyopathy
• Hypertrophic cardiomyopathy
• Mitral valve prolapse
• Myocardial bridging
• Long QT syndrome
• Sudden cardiac death
• Aortic dissection
• Vasovagal syncope

GUIDELINE CATEGORY

• Assessment of Therapeutic Effectiveness
• Prevention
• Treatment

CLINICAL SPECIALTY

• Cardiology
• Emergency Medicine
• Family Practice
• Internal Medicine
• Preventive Medicine

INTENDED USERS

• Physicians

GUIDELINE OBJECTIVE(S)

• To review the rationale and clinical evidence for the use of beta-adrenergic blockers in patients with cardiovascular disease